Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli

Enterotoxigenic Escherichia coli (ETEC) contributes significantly to the substantial burden of infectious diarrhea among children living in low- and middle-income countries. In the absence of a vaccine for ETEC, children succumb to acute dehydration as well as nondiarrheal sequelae related to these infections, including malnutrition. ABSTRACT Enterotoxigenic Escherichia coli (ETEC) contributes significantly to the substantial burden of infectious diarrhea among children living in low- and middle-income countries. In the absence of a vaccine for ETEC, children succumb to acute dehydration as well as nondiarrheal sequelae related to these infections, including malnutrition. The considerable diversity of ETEC genomes has complicated canonical vaccine development approaches defined by a subset of ETEC pathovar-specific antigens known as colonization factors (CFs). To identify additional conserved immunogens unique to this pathovar, we employed an “open-aperture” approach to capture all potential conserved ETEC surface antigens, in which we mined the genomic sequences of 89 ETEC isolates, bioinformatically selected potential surface-exposed pathovar-specific antigens conserved in more than 40% of the genomes (n = 118), and assembled the representative proteins onto microarrays, complemented with known or putative colonization factor subunit molecules (n = 52) and toxin subunits. These arrays were then used to interrogate samples from individuals with acute symptomatic ETEC infections. Surprisingly, in this approach, we found that immune responses were largely constrained to a small number of antigens, including individual colonization factor antigens and EtpA, an extracellular adhesin. In a Bangladeshi cohort of naturally infected children <2 years of age, both EtpA and a second antigen, EatA, elicited significant serologic responses that were associated with protection from symptomatic illness. In addition, children infected with ETEC isolates bearing either etpA or eatA genes were significantly more likely to develop symptomatic disease. These studies support a role for antigens not presently targeted by vaccines (noncanonical) in virulence and the development of adaptive immune responses during ETEC infections. These findings may inform vaccine design efforts to complement existing approaches.

[1]  M. Mitreva,et al.  Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli , 2019, PLoS neglected tropical diseases.

[2]  Arlo Z. Randall,et al.  Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection , 2019, npj Vaccines.

[3]  S. Chakraborty,et al.  How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions , 2019, Vaccine.

[4]  F. Qadri,et al.  Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development , 2019, Vaccine.

[5]  J. Fleckenstein,et al.  Enterotoxigenic Escherichia coli Infections , 2019, Current Infectious Disease Reports.

[6]  K. Bagamian,et al.  Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis , 2019, The Lancet. Global health.

[7]  R. Black,et al.  Estimating the true burden of an enteric pathogen: enterotoxigenic Escherichia coli and Shigella spp. , 2018, The Lancet. Infectious diseases.

[8]  Arlo Z. Randall,et al.  Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development , 2018, The Journal of infectious diseases.

[9]  T. H. Nguyen,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, The Lancet. Infectious diseases.

[10]  P. Puntervoll,et al.  Development of an enterotoxigenic Escherichia coli vaccine based on the heat-stable toxin , 2018, Human vaccines & immunotherapeutics.

[11]  J. Clements,et al.  The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT , 2018, mSphere.

[12]  T. Vickers,et al.  Enterotoxigenic Escherichia coli–blood group A interactions intensify diarrheal severity , 2018, The Journal of clinical investigation.

[13]  Peter G. Smith,et al.  WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report. , 2018, Vaccine.

[14]  Peter G. Smith,et al.  Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy , 2019, Vaccine.

[15]  D. Rasko,et al.  Insights into enterotoxigenic Escherichia coli diversity in Bangladesh utilizing genomic epidemiology , 2017, Scientific Reports.

[16]  U. Parashar,et al.  Correlates of protection for enteric vaccines. , 2017, Vaccine.

[17]  W. Petri,et al.  Environmental Enteropathy: Elusive but Significant Subclinical Abnormalities in Developing Countries , 2016, EBioMedicine.

[18]  T. Vickers,et al.  Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin , 2016, Clinical and Vaccine Immunology.

[19]  P. Puntervoll,et al.  Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coli , 2016, Infection and Immunity.

[20]  Mark A. Miller,et al.  Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). , 2015, The Lancet. Global health.

[21]  C. Fraser,et al.  Examination of the Enterotoxigenic Escherichia coli Population Structure during Human Infection , 2015, mBio.

[22]  D. Rasko,et al.  Conservation and Immunogenicity of Novel Antigens in Diverse Isolates of Enterotoxigenic Escherichia coli , 2015, PLoS neglected tropical diseases.

[23]  J. Gregory Caporaso,et al.  The large-scale blast score ratio (LS-BSR) pipeline: a method to rapidly compare genetic content between bacterial genomes , 2014, PeerJ.

[24]  T. Vickers,et al.  EatA, an Immunogenic Protective Antigen of Enterotoxigenic Escherichia coli, Degrades Intestinal Mucin , 2013, Infection and Immunity.

[25]  Inacio Mandomando,et al.  Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study , 2013, The Lancet.

[26]  David A Rasko,et al.  Refining the pathovar paradigm via phylogenomics of the attaching and effacing Escherichia coli , 2013, Proceedings of the National Academy of Sciences.

[27]  Paul Keim,et al.  Evolution of a Pathogen: A Comparative Genomics Analysis Identifies a Genetic Pathway to Pathogenesis in Acinetobacter , 2013, PloS one.

[28]  S. Knight,et al.  Crystal structure of enterotoxigenic Escherichia coli colonization factor CS6 reveals a novel type of functional assembly , 2012, Molecular microbiology.

[29]  P. Gilbert,et al.  Nomenclature for immune correlates of protection after vaccination. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  Tim J. Anderson,et al.  DEVELOPMENT STRATEGY , 2012 .

[31]  R. Kansal,et al.  Adhesin Degradation Accelerates Delivery of Heat-labile Toxin by Enterotoxigenic Escherichia coli* , 2011, The Journal of Biological Chemistry.

[32]  Samuel V. Angiuoli,et al.  The IGS Standard Operating Procedure for Automated Prokaryotic Annotation , 2011, Standards in genomic sciences.

[33]  F. Qadri,et al.  Immune responses to Helicobacter pylori infection in Bangladeshi children during their first two years of life and the association between maternal antibodies and onset of infection. , 2010, The Journal of infectious diseases.

[34]  Robert C. Edgar,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .

[35]  Nicola K. Petty,et al.  A Commensal Gone Bad: Complete Genome Sequence of the Prototypical Enterotoxigenic Escherichia coli Strain H10407 , 2010, Journal of bacteriology.

[36]  Martin Ester,et al.  PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..

[37]  F. Qadri,et al.  Enterotoxigenic Escherichia coli Elicits Immune Responses to Multiple Surface Proteins , 2010, Infection and Immunity.

[38]  Jonathan Crabtree,et al.  Ergatis: a web interface and scalable software system for bioinformatics workflows , 2010, Bioinform..

[39]  J. Fleckenstein,et al.  Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model. , 2009, Vaccine.

[40]  George M. Hilliard,et al.  Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells , 2008, Nature.

[41]  K. Roy,et al.  The EtpA Exoprotein of Enterotoxigenic Escherichia coli Promotes Intestinal Colonization and Is a Protective Antigen in an Experimental Model of Murine Infection , 2008, Infection and Immunity.

[42]  J. Tobias,et al.  Preexisting antibodies to homologous colonization factors and heat-labile toxin in serum, and the risk to develop enterotoxigenic Escherichia coli-associated diarrhea. , 2008, Diagnostic microbiology and infectious disease.

[43]  F. Qadri,et al.  Disease Burden Due to Enterotoxigenic Escherichia coli in the First 2 Years of Life in an Urban Community in Bangladesh , 2007, Infection and Immunity.

[44]  F. Qadri,et al.  Mucosal and Systemic Immune Responses in Patients with Diarrhea Due to CS6-Expressing Enterotoxigenic Escherichia coli , 2007, Infection and Immunity.

[45]  R. Agarwala,et al.  Composition-based statistics and translated nucleotide searches: Improving the TBLASTN module of BLAST , 2006, BMC Biology.

[46]  M. Burkitt,et al.  Identification of a Two-Partner Secretion Locus of Enterotoxigenic Escherichia coli , 2006, Infection and Immunity.

[47]  Hu Chen,et al.  SubLoc: a server/client suite for protein subcellular location based on SOAP , 2006, Bioinform..

[48]  R. Frenck,et al.  Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. , 2005, The Journal of infectious diseases.

[49]  Pierre Baldi,et al.  Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Jacques Ravel,et al.  Visualization of comparative genomic analyses by BLAST score ratio , 2005, BMC Bioinformatics.

[51]  Jenn-Kang Hwang,et al.  Predicting subcellular localization of proteins for Gram‐negative bacteria by support vector machines based on n‐peptide compositions , 2004, Protein science : a publication of the Protein Society.

[52]  Kenneth P Allen,et al.  Identification and Molecular Characterization of EatA, an Autotransporter Protein of Enterotoxigenic Escherichia coli , 2004, Infection and Immunity.

[53]  H. Gjessing,et al.  Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study , 2003, The Lancet.

[54]  D. Sack,et al.  Development of a Novel In Vitro Assay (ALS Assay) for Evaluation of Vaccine-Induced Antibody Secretion from Circulating Mucosal Lymphocytes , 2001, Clinical Diagnostic Laboratory Immunology.

[55]  A. Svennerholm,et al.  Colonization factors of human enterotoxigenic Escherichia coli (ETEC). , 1996, Trends in microbiology.

[56]  A. Mccarthy Development , 1996, Current Opinion in Neurobiology.

[57]  B. Forrest IDENTIFICATION OF AN INTESTINAL IMMUNE RESPONSE USING PERIPHERAL BLOOD LYMPHOCYTES , 1988, The Lancet.

[58]  V. Tsang,et al.  Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. , 1980, Clinical chemistry.

[59]  D. Nalin,et al.  Immunity to Enterotoxigenic Escherichia coli , 1979, Infection and immunity.

[60]  D. Nalin,et al.  Cholera-like toxic effect of culture filtrates of Escherichia coli. , 1974, The Journal of infectious diseases.

[61]  R. Sack,et al.  Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. , 1971, The Journal of infectious diseases.

[62]  S. De,et al.  A study of the pathogenicity of strains of Bacterium coli from acute and chronic enteritis. , 1956, The Journal of pathology and bacteriology.